BWI: VLifeMDSTM 3.5 to be Used for Research at Center for Disease Control (CDC), Atlanta, GA, USA

Press release from Business Wire India
Source: VLife Sciences Technologies Pvt. Ltd. (VLife)
Monday, October 04, 2010 10:35 AM IST (05:05 AM GMT)
Editors: General: Consumer interest, People; Business: Advertising, PR & marketing, Business services, Chemicals, Healthcare, biotechnology & pharmaceutical; Healthcare
--------------------------------------------------
VLifeMDSTM 3.5 to be Used for Research at Center for Disease Control (CDC), Atlanta, GA, USA


Pune, Maharashtra, India, Monday, October 04, 2010 -- (Business Wire India) -- VLife Sciences Technologies Pvt. Ltd. today announced that The Agency for Toxic Substances and Disease Registry (ATSDR), at Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA will use its flagship software product VLifeMDSTM 3.5, including its patented technology GQSAR and hybrid lead optimization approach VLife SCOPE (Structure Based Compound Optimization Prioritization and Evolution), for conducting cutting edge research in drug discovery and toxicology studies.

With this, VLife has added yet another top level research institute in the world to its list of users who have adopted this advanced technology platform. 'We are very pleased to be associated with one of the finest center of disease control in the world. We are confident that with this advanced software the research community at ATSDR, Atlanta, USA will be able to expedite their research projects and further improve their R & D productivity', said VLife's CEO Mr. Supreet Deshpande.

About ATSDR, CDC, Atlanta, GA, USA

The Agency for Toxic Substances and Disease Registry (ATSDR),CDC based in Atlanta, Georgia, is a federal public health agency of the U.S. Department of Health and Human Services. ATSDR serves the public by using the best science, taking responsive public health actions, and providing trusted health information to prevent harmful exposures and diseases related to toxic substances.

About VLife Sciences Technologies Pvt. Ltd.

VLife Sciences Technologies Pvt. Ltd. (VLife) is the pioneering organization in developing technologies for computer aided drug and molecular discovery in India. Besides VLifeMDSTM 3.5, VLife offers specialty software products like QSARProTM, ChemXplorTM and BioPredictaTM. The company also provides professional consulting and project based research services to life sciences organizations for computer aided discovery.

For more details visit: www.vlifesciences.com or contact us at: info@vlifesciences.com

About VLifeMDSTM 3.5

VLifeMDSTM is a comprehensive software for computer aided drug discovery (CADD) that works on a conventional PC and Microsoft Windows® operating system. VLifeMDSTM 3.5 includes advanced technologies like GQSARTM and VLife SCOPE that overcome challenges in lead optimization. It also implements GRIPTM docking that offers superior docking results in terms of accuracy as well as speed and which facilitates a direct approach to drug discovery. Apart from these unique features the software also has extensive facilities for visualizing and optimizing a library of molecules, for generating a combinatorial library, for chemoinformatics and for calculating molecular properties. It also provides tools for protein analysis, homology modeling and for conducting 2D QSAR and 3D QSAR (kNN-MFA) studies.



CONTACT DETAILS
Yogesh Wagh, VLife Sciences Technologies Pvt. Ltd. (VLife), +91 (20) 27291590, yogeshw@vlifesciences.com

KEYWORDS
CONSUMER, PEOPLE, MARKETING, BUSINESS SERVICES, CHEMICALS, HEALTHCARE, HEALTHCARE

If you wish to change your Business Wire India selection please click on this link http://www.businesswireindia.com/media/news.asp and use your personal username and password to login.

Submit your press release at http://www.businesswireindia.com